Nanosphere gets FDA Verigene SP, Flu Test Approval

Tue, 10/13/2009 - 5:10am
NORTHBROOK, Ill. (AP) — Molecular diagnostics maker Nanosphere Inc. said Tuesday the Food and Drug Administration approved its automated Verigene SP system, and a test for the flu and respiratory syncytial virus. Nanosphere said the FDA granted marketing clearance to both products. On the Verigene SP system, samples are taken from a patient and processed at the same location, with results available in a few hours, the company said. The new testing product can detect influenza A and B strains, as well as RSV. RSV produces mild symptoms similar to a cold, but in young and elderly patients, or people with chronic health problems or heart and lung disease, it can cause pneumonia or death.

Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.